Featuring perspectives from Dr Bradley J Monk,
Dr David M O’Malley, Ms Kathryn M Schlenker and Ms Jaclyn Shaver,
moderated by Dr O’Malley, including the following topics:
Introduction (00:00)
Overview of Ovarian Cancer
(OC) (2:12)
Role of PARP Inhibitors in
Advanced OC (4:56)
Current and Potential
Future Role of Mirvetuximab Soravtansine in OC (28:45)
Role of Relacorilant in
Advanced OC (57:08)
Utility of Immune
Checkpoint Inhibition in Advanced OC (1:14:12)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.